Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE.
about
COPD and its comorbidities: Impact, measurement and mechanismsComorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and ManagementThe effect of comorbidities on COPD assessment: a pilot studyApplication of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.Prognostic utility of the 2011 GOLD classification and other multidimensional tools in Asian COPD patients: a prospective cohort study.Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD.Year in review 2014. Paediatric and adult clinical studies.Disease Modification in Emphysema Related to Alpha-1 Antitrypsin Deficiency.Comparing the 2007 and 2011 GOLD Classifications as Predictors of all-Cause Mortality and Morbidity in COPD.Classification of Airflow Limitation Based on z-Score Underestimates Mortality in Patients with Chronic Obstructive Pulmonary Disease.Prognostic Indices and Mortality Prediction in COPD Caused by Biomass Smoke Exposure.Role of BMI, airflow obstruction, St George's Respiratory Questionnaire and age index in prognostication of Asian COPD.Exercise Ventilatory Inefficiency Adds to Lung Function in Predicting Mortality in COPD.Respiratory parameters predict poor outcome in COPD patients, category GOLD 2017 B.Pulmonary arterial enlargement predicts long-term survival in COPD patients.GOLD 2017 recommendations for COPD patients: toward a more personalized approachComparison of the clinical characteristics and comprehensive assessments of the 2011 and 2017 GOLD classifications for patients with COPD in ChinaPredictors of mortality in patients with COPD after 9 years
P2860
Q26786812-5EDCD8AB-95B8-4798-8DE9-EEAF0BCFDA95Q26799659-BBD6A13C-0EC8-49DA-BDE0-BFD1F37DD075Q35142397-2AE7776D-9C87-4BF3-998E-A70179D213A9Q35915157-F9B5B1C3-629D-482C-BB80-CF74C6AB03DDQ35981939-5F4C4B6B-6DB4-4770-9507-B06571FF111EQ36858183-89B6E5BF-2C22-4AA9-BC9B-FD78B6282DD5Q37628063-38F55B9F-DC3B-4A74-A534-D74002658A59Q38376166-3FCE1847-B598-4366-8AF4-6D4E009CE5E3Q38832928-11689ACB-1EC7-475B-9E26-4C999B8F0126Q39576261-8BD1347E-C389-4DB5-BAE1-5397AF973F26Q40287615-F31B7825-EBBB-44B3-9B19-0BBBDD73AF2AQ46735568-7894F845-740D-4712-8590-0A14FA0DCB48Q47665614-0622EA0E-C30B-44E0-BA59-B6588621DE9BQ51532447-0A9A9263-523C-4100-B816-CE2C83E54509Q52805734-FE311273-C7AE-414A-B64C-12A13CB6E2A5Q54940823-12600A6A-F2B7-4EBA-BA75-CA841D86318AQ55981706-4DF5AA93-C6B6-4D5C-B922-D0A8A99F040EQ57490325-637FAA1F-1234-4478-A153-7D795B4CD655Q58543923-EC359662-BF8C-43BC-9DB8-EDCD56659D21
P2860
Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Prognostic evaluation of COPD ...... e COPD comorbidity index COTE.
@en
Prognostic evaluation of COPD ...... e COPD comorbidity index COTE.
@nl
type
label
Prognostic evaluation of COPD ...... e COPD comorbidity index COTE.
@en
Prognostic evaluation of COPD ...... e COPD comorbidity index COTE.
@nl
prefLabel
Prognostic evaluation of COPD ...... e COPD comorbidity index COTE.
@en
Prognostic evaluation of COPD ...... e COPD comorbidity index COTE.
@nl
P2093
P2860
P1433
P1476
Prognostic evaluation of COPD ...... e COPD comorbidity index COTE.
@en
P2093
Bartolome R Celli
Carlos Cabrera
Ciro Casanova
Claudia Cote
Jorge Zagaceta
Jose M Marín
Juan Berto
Miguel Divo
Pablo Sanchez-Salcedo
Santiago Carrizo
P2860
P304
P356
10.1136/THORAXJNL-2014-205770
P407
P577
2014-06-26T00:00:00Z